18th Oct 2024 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer
29th Sep 2021 Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer
